Physician profile
Christopher J Young
NPI 1588067177
$4,589.33
in general payments reported to CMS, 2019-2025
11 companies · $312 in 2025
The $312 reported for 2025 was more than what 84% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.59 · 2020: $459 · 2021: $555 · 2022: $486 · 2023: $2,080 · 2024: $612 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,871 · Education: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,870.58 |
| Education | $1,132.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $2,218.90 | 2020-2025 | Cavitron, Vortex Blue Conform Fit, Cerec |
| Patterson Companies, INC. | $1,521.14 | 2020-2025 | |
| Dentsply LLC | $550.00 | 2021-2022 | |
| Zimvie INC. | $110.61 | 2024 | |
| Zimmer Biomet Holdings, INC. | $56.00 | 2019 | |
| Nobel Biocare USA | $44.45 | 2023 | Nobelactive |
| Colgate Oral Pharmaceuticals, INC. | $29.04 | 2023 | |
| Envista Holdings Corporation | $17.57 | 2024 | Kavo Op300 |
| Tulsa Dental Products LLC | $15.15 | 2019 | |
| Straumann USA LLC | $14.44 | 2019 | |
| Ultradent Products INC | $12.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.